S 944 New Jersey Senate · 2026-2027 Regular Session

Expands epinephrine administration mechanisms permitted in schools, institutions of higher education, and youth camps.

This bill expands school staff's ability to administer epinephrine auto-injectors to students experiencing severe allergic reactions (anaphylaxis) in New Jersey schools, colleges, and youth camps. It allows trained school nurses or designated staff to give epinephrine without prior parental consent if they believe a student is having an anaphylactic reaction, even if the student hasn't been identified as needing it or parental forms are incomplete. Schools must store epinephrine securely but accessibly, train staff, maintain backup supplies, and follow specific protocols for emergency use and hospital transport. The law requires parental written authorization for routine use, but streamlines emergency administration to save critical time during allergic emergencies. It directly affects all New Jersey public and nonpublic schools, colleges, and youth camps with students at risk of anaphylaxis.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026 Last action Jan 13, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 4 co-sponsors

Sponsors